NicholasPeterGiustiniMD

Oncology • Seattle, WA

Thoracic Cancer

Attending

Join to view full profile

Dr. Giustini is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Giustini's full profile

Already have an account?

Office
University of Washington
Seattle, WA 98104
Is this information wrong?

Education & Training

University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2015 - 2018
Keck School of Medicine of the University of Southern CaliforniaClass of 2015

Certifications & Licensure

WA State Medical License 2021 - 2026
CA State Medical License 2017 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

1 citations
Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives.
Matthew Triplette, Meagan C Brown, Madison Snidarich, Jehan Z Budak, Nicholas Giustini, Nicholas Murphy, Perrin E Romine, Bryan J Weiner, Kristina Crothers> ;American Journal of Preventive Medicine. 2023 Oct 1
1 citations
Development of Neuropathic Arthropathy With Entrectinib: Case Report.
Nicholas P Giustini, Hanna Oh, Keith D Eaton> ;JTO Clinical and Research Reports. 2022 Nov 1
Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on: Case...
Nicholas P Giustini, Sandip Pravin Patel, Nathaniel J Myall, José Fernando do Prado Moura, Amit Kulkarni, Richard C Chao, Heather Wakelee, Lyudmila Bazhenova> ;JCO Precision Oncology. 2022 Aug 1
1 citations
An overview of alectinib hydrochloride as a treatment option for ALK positive non-small cell lung cancer.
Shiruyeh Schokrpur, Van Hilburn, Nicholas P. Giustini, Lyudmila Bazhenova> ;Expert Opinion on Pharmacotherapy. 2021 Jul 6
15 citations
Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs).
Nicholas P. Giustini, Lyudmila Bazhenova> ;Lung Cancer. 2021 Mar 25
14 citations
Advances in Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Targeted Therapy.
Nicholas P. Giustini, Ah-Reum Jeong, James Buturla, Lyudmila Bazhenova> ;Clinics in Chest Medicine. 2020 Jun 1
3 citations
ROS1-rearranged Non-small Cell Lung Cancer.
Nicholas P. Giustini, Lyudmila Bazhenova> ;Thoracic Surgery Clinics. 2020 May 1
27 citations
Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature.
Nicholas Giustini, Nicholas M. Bernthal, Susan V. Bukata, Arun S. Singh> ;Clinical Sarcoma Research. 2018 Jul 10
14 citations
Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragment
Christopher M. Rose, Michael J. Hayes, Gregory R. Stettler, Scott F. Hickey, Trevor M. Axelrod, Nicholas P. Giustini, Steven W. Suljak> ;The Analyst. 2010 Oct 18
Join now to see all

Hospital Affiliations

UW Medicine/Harborview Medical CenterSeattle, Washington
Fred Hutchinson Cancer CenterSeattle, Washington